B细胞疾病与姜黄素
B-Cell Disorders and Curcumin.
作者信息
Golombick Terry, Diamond Terrence H, Manoharan Arumugam, Ramakrishna Rajeev
机构信息
1 St George Hospital, Sydney, New South Wales, Australia.
2 University of Wollongong, Wollongong, NSW, Australia.
出版信息
Integr Cancer Ther. 2017 Sep;16(3):255-257. doi: 10.1177/1534735415622013. Epub 2015 Dec 16.
Abstract
Clinical studies with patients with early hematological malignancies (ie, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or stage 0/1 chronic lymphocytic leukemia) suggest that early intervention with curcumin, derived from the spice turmeric, may lead to prolonged survival and delay in progressive disease in some of these patients.
摘要
针对早期血液系统恶性肿瘤患者（即意义未明的单克隆丙种球蛋白病、冒烟型多发性骨髓瘤或0/1期慢性淋巴细胞白血病）的临床研究表明，源自香料姜黄的姜黄素进行早期干预，可能会使其中部分患者延长生存期并延缓疾病进展。
相似文献
1
B-Cell Disorders and Curcumin.
Integr Cancer Ther. 2017 Sep;16(3):255-257. doi: 10.1177/1534735415622013. Epub 2015 Dec 16.
2
Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study.
Integr Cancer Ther. 2016 Jun;15(2):183-9. doi: 10.1177/1534735416635742. Epub 2016 May 6.
3
Multitargeting by turmeric, the golden spice: From kitchen to clinic.
Mol Nutr Food Res. 2013 Sep;57(9):1510-28. doi: 10.1002/mnfr.201100741. Epub 2012 Aug 13.
4
Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.
Am J Hematol. 2012 May;87(5):455-60. doi: 10.1002/ajh.23159. Epub 2012 Apr 4.
5
Turmeric and green tea: a recipe for the treatment of B-chronic lymphocytic leukemia.
Clin Cancer Res. 2009 Feb 15;15(4):1123-5. doi: 10.1158/1078-0432.CCR-08-2791.
6
Identification of a novel compound (β-sesquiphellandrene) from turmeric (Curcuma longa) with anticancer potential: comparison with curcumin.
Invest New Drugs. 2015 Dec;33(6):1175-86. doi: 10.1007/s10637-015-0296-5. Epub 2015 Nov 2.
7
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Hematol Oncol Clin North Am. 2014 Oct;28(5):775-90. doi: 10.1016/j.hoc.2014.06.005. Epub 2014 Jul 22.
8
Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy.
Case Rep Hematol. 2015;2015:910528. doi: 10.1155/2015/910528. Epub 2015 Jun 25.
9
Curcumin, a potential therapeutic candidate for retinal diseases.
Mol Nutr Food Res. 2013 Sep;57(9):1557-68. doi: 10.1002/mnfr.201200718. Epub 2013 Feb 18.
10
[Turmeric - not only spice].
Pol Merkur Lekarski. 2017 Jun 23;42(252):227-230.
引用本文的文献
1
Bioactive Phytoconstituents and Their Therapeutic Potentials in the Treatment of Haematological Cancers: A Review.
Life (Basel). 2023 Jun 21;13(7):1422. doi: 10.3390/life13071422.
2
The Anti-Leukemic Activity of Natural Compounds.
Molecules. 2021 May 5;26(9):2709. doi: 10.3390/molecules26092709.
3
Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.
Biomolecules. 2021 Mar 7;11(3):392. doi: 10.3390/biom11030392.
4
Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.
Curr Oncol Rep. 2017 Oct 14;19(12):79. doi: 10.1007/s11912-017-0635-0.
本文引用的文献
1
Stabilisation of Laryngeal AL Amyloidosis with Long Term Curcumin Therapy.
Case Rep Hematol. 2015;2015:910528. doi: 10.1155/2015/910528. Epub 2015 Jun 25.
2
The multifaceted role of curcumin in cancer prevention and treatment.
Molecules. 2015 Feb 5;20(2):2728-69. doi: 10.3390/molecules20022728.
3
Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.
PLoS One. 2014 Oct 6;9(10):e108326. doi: 10.1371/journal.pone.0108326. eCollection 2014.
4
Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy.
Clin Ophthalmol. 2012;6:801-6. doi: 10.2147/OPTH.S31859. Epub 2012 May 28.
5
Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.
Am J Hematol. 2012 May;87(5):455-60. doi: 10.1002/ajh.23159. Epub 2012 Apr 4.
6
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies.
Blood. 2011 May 26;117(21):5573-81. doi: 10.1182/blood-2011-01-270140. Epub 2011 Mar 25.
7
Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation.
J Nat Prod. 2011 Apr 25;74(4):664-9. doi: 10.1021/np1007262. Epub 2011 Mar 17.
8
Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia.
Leuk Lymphoma. 2010 Oct;51(10):1829-36. doi: 10.3109/10428194.2010.503820.
9
Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendations.
J Clin Oncol. 2010 Feb 1;28(4):690-7. doi: 10.1200/JCO.2009.22.2257. Epub 2009 Dec 21.
10
The potential role of curcumin in patients with monoclonal gammopathy of undefined significance--its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker.
Clin Cancer Res. 2009 Sep 15;15(18):5917-22. doi: 10.1158/1078-0432.CCR-08-2217. Epub 2009 Sep 8.
Zotero 插件